Article Information
History
- August 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chen-Yi Liao1,
- Jasmijn HM Hundscheid1,
- Justin Crawford2,
- Peter ten Dijke3,
- Beatrice Coorneaert2 and
- Erik HJ Danen1,4
- 1Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands
- 2Galapagos NV, Mechelen, Belgium
- 3Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands
- ↵4Correspondence to Erik HJ Danen, e.danen{at}lacdr.leidenuniv.nl
Posted August 27, 2024.
Novel high throughput 3D ECM remodeling assay identifies MEK as key driver of fibrotic fibroblast activity
